| 1 | JNJ | Johnson & Johnson | 7.47% |
| 2 | ABBV | AbbVie Inc. | 7.22% |
| 3 | PFE | Pfizer Inc. | 7.02% |
| 4 | MRK | Merck & Co., Inc. | 6.80% |
| 5 | BMY | Bristol-Myers Squibb Company | 6.45% |
| 6 | UTHR | United Therapeutics Corporation | 4.05% |
| 7 | ZTS | Zoetis Inc. | 4.04% |
| 8 | GILD | Gilead Sciences, Inc. | 3.91% |
| 9 | BIIB | Biogen Inc. | 3.77% |
| 10 | VTRS | Viatris Inc. | 3.75% |
| 11 | AMGN | Amgen Inc. | 3.75% |
| 12 | LLY | Eli Lilly and Company | 3.32% |
| 13 | JAZZ | Jazz Pharmaceuticals plc | 3.08% |
| 14 | REGN | Regeneron Pharmaceuticals, Inc. | 2.80% |
| 15 | EXEL | Exelixis, Inc. | 2.34% |
| 16 | ELAN | Elanco Animal Health Incorporated | 2.26% |
| 17 | CRL | Charles River Laboratories International, Inc. | 2.00% |
| 18 | OGN | Organon & Co. | 1.84% |
| 19 | MEDP | Medpace Holdings, Inc. | 1.79% |
| 20 | ILMN | Illumina, Inc. | 1.72% |
| 21 | NBIX | Neurocrine Biosciences, Inc. | 1.58% |
| 22 | HALO | Halozyme Therapeutics, Inc. | 1.37% |
| 23 | ALKS | Alkermes plc | 1.12% |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 1.11% |
| 25 | PRGO | Perrigo Company plc | 0.94% |
| View FTXH holdings |